Cargando…
Anti-inflammatory Nanomedicine for Cardiovascular Disease
Coronary artery disease, in the development of which inflammation mediated by innate immune cells plays a critical role, is one of the leading causes of death worldwide. The 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) are a widely used lipid-lowering drug that has lipid-inde...
Autores principales: | Katsuki, Shunsuke, Matoba, Tetsuya, Koga, Jun-ichiro, Nakano, Kaku, Egashira, Kensuke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5743792/ https://www.ncbi.nlm.nih.gov/pubmed/29312961 http://dx.doi.org/10.3389/fcvm.2017.00087 |
Ejemplares similares
-
Nanoparticle-Mediated Delivery of Pitavastatin to Monocytes/Macrophages Inhibits Angiotensin II-Induced Abdominal Aortic Aneurysm Formation in
Apoe
(−/−)
Mice
por: Katsuki, Shunsuke, et al.
Publicado: (2022) -
Nanoparticle-Mediated Delivery of Irbesartan Induces Cardioprotection from Myocardial Ischemia-Reperfusion Injury by Antagonizing Monocyte-Mediated Inflammation
por: Nakano, Yasuhiro, et al.
Publicado: (2016) -
A Translational Study of a New Therapeutic Approach for Acute Myocardial Infarction: Nanoparticle-Mediated Delivery of Pitavastatin into Reperfused Myocardium Reduces Ischemia-Reperfusion Injury in a Preclinical Porcine Model
por: Ichimura, Kenzo, et al.
Publicado: (2016) -
Nanoparticle‐Mediated Simultaneous Targeting of Mitochondrial Injury and Inflammation Attenuates Myocardial Ischemia‐Reperfusion Injury
por: Ikeda, Gentaro, et al.
Publicado: (2021) -
Editorial: Mitochondria, metabolism and cardiovascular diseases
por: Koga, Jun-ichiro, et al.
Publicado: (2022)